Fagan EB[au] - Search Results

Year	Number of Results
2006	1
2007	1
2009	2
2013	2
2015	1
2016	1
2017	5
2018	2
2019	3
2020	6
2021	1
2022	1
2023	2
2024	0

1

High-dose tramadol conversion to buprenorphine-naloxone.

Kirk JK, Boyd CT, Cassidy-Vu L, McRae LP, Strickland HE, Fagan EB. Kirk JK, et al. Among authors: fagan eb. J Opioid Manag. 2023 Mar-Apr;19(2):187-190. doi: 10.5055/jom.2023.0774. J Opioid Manag. 2023. PMID: 37270427

2

Teaching Opioid Tapering Through Guided Instruction.

Austin RC, Fusco CW, Fagan EB, Drake E, Pacious J, Dickens H, Galvin SL, Wilson CG. Austin RC, et al. Among authors: fagan eb. Fam Med. 2019 May;51(5):434-437. doi: 10.22454/FamMed.2019.502509. Fam Med. 2019. PMID: 31081916 Free article.

3

Clinical inquiries. What's the best treatment for sebaceous cysts?

Moore RB, Fagan EB, Hulkower S, Skolnik DC, O'Sullivan G. Moore RB, et al. Among authors: fagan eb. J Fam Pract. 2007 Apr;56(4):315-6. J Fam Pract. 2007. PMID: 17403333 Review. No abstract available.

4

Prescribing psychologists: Forgotten providers in the battle against opioid use disorder.

Hughes PM, Phillips DC, Fagan EB. Hughes PM, et al. Among authors: fagan eb. Addiction. 2023 Jul;118(7):1398-1399. doi: 10.1111/add.16204. Epub 2023 Apr 27. Addiction. 2023. PMID: 37039245 No abstract available.

5

Providing Office-Based Treatment of Opioid Use Disorder.

Wilson CG, Fagan EB. Wilson CG, et al. Among authors: fagan eb. Ann Fam Med. 2017 Sep;15(5):481. doi: 10.1370/afm.2139. Ann Fam Med. 2017. PMID: 28893820 Free PMC article. No abstract available.

6

The Road to Rural Primary Care: A Narrative Review of Factors That Help Develop, Recruit, and Retain Rural Primary Care Physicians.

Parlier AB, Galvin SL, Thach S, Kruidenier D, Fagan EB. Parlier AB, et al. Among authors: fagan eb. Acad Med. 2018 Jan;93(1):130-140. doi: 10.1097/ACM.0000000000001839. Acad Med. 2018. PMID: 28767498 Review.

7

A Financial Model for Team-Based Opioid Use Disorder Treatment.

Farrar M, White Z, Hulkower S, Fagan EB, Wilson CG. Farrar M, et al. Among authors: fagan eb. J Am Board Fam Med. 2020 Jan-Feb;33(1):124-128. doi: 10.3122/jabfm.2020.01.190228. J Am Board Fam Med. 2020. PMID: 31907253 Free article.

8

Long-acting, Injectable Buprenorphine: Great Promise, but Significant Barriers to Use.

Major E, Fusco CW, White Z, Wilson CG, Fagan EB. Major E, et al. Among authors: fagan eb. N C Med J. 2020 May-Jun;81(3):210-211. doi: 10.18043/ncm.81.3.210. N C Med J. 2020. PMID: 32366637 Free article. No abstract available.

9

Evaluation of a pharmacist-led naloxone coprescribing program in primary care.

Cariveau D, Fay AE, Baker D, Fagan EB, Wilson CG. Cariveau D, et al. Among authors: fagan eb. J Am Pharm Assoc (2003). 2019 Nov-Dec;59(6):867-871. doi: 10.1016/j.japh.2019.07.012. Epub 2019 Aug 26. J Am Pharm Assoc (2003). 2019. PMID: 31466899

10

A Primary Care Response to COVID-19 for Patients with an Opioid Use Disorder.

Wilson CG, Ramage M, Fagan EB. Wilson CG, et al. Among authors: fagan eb. J Rural Health. 2021 Jan;37(1):169-171. doi: 10.1111/jrh.12438. Epub 2020 Jun 2. J Rural Health. 2021. PMID: 32277732 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

27 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year